Novartis phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failure Read more
Glenmark Generics announces settlement of Paragraph IV litigation with Janssen Pharmaceuticals Read more
CDSCO drafts guidelines on recall and rapid alert system for drugs including biologics and vaccines Read more